Stefan Kubicka

10.2k citations
162 papers · 6.7k · 1 hit paper · h-index 46

Impact in

  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 1%
    • Colorectal Cancer Treatments and Studies
    • CAR-T cell therapy research

Papers in

    • Colorectal Cancer Treatments and Studies 39
    • Cancer Treatment and Pharmacology 16
    • Cholangiocarcinoma and Gallbladder Cancer Studies 15

Stefan Kubicka

153 papers receiving 6.5k citations

Stefan Kubicka's Hit Papers

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial 2012 · 865 citations
8650+4+9Years since publication250500750

Peers

Stefan Kubicka
Comparison fields: 5 of 123
  • Hepatology 1.6k
  • Oncology 2.1k
  • Cancer Research 637
  • Epidemiology 1.1k
  • Molecular Biology 2.2k
Replace Hiromitsu Saisho with:
Hiromitsu Saisho Japan
Massimo Pignatelli United Kingdom
Jiro Fujimoto Japan
Masayoshi Kage Japan
Hey‐Chi Hsu Taiwan
Takenori Ochiai Japan
Jean–François Fléjou France
Julie M. Cherrington United States
Hiroyuki Marusawa Japan
Thomas Longerich Germany
Stefan Kubicka relative to Hiromitsu Saisho Japan Hiromitsu Saisho's profile →
Citations per field
00.5×3.3×
Hiromitsu Saisho · 1×
Citations per year

Countries citing papers authored by Stefan Kubicka

Since Specialization
Citations

This map shows the geographic impact of Stefan Kubicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Kubicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Kubicka more than expected).

Fields of papers citing papers by Stefan Kubicka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Kubicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Kubicka. The network helps show where Stefan Kubicka may publish in the future.

Co-authors

The 25 scholars most cited alongside Stefan Kubicka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stefan Kubicka Line = papers co-authored together Stefan Kubicka links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 162 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
Hit paper breakdown →
2012865
2 2008358
3 2003326
4 2015167
5 1999164
6 2005158
7 2006154
8 2003151
9
A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.
2003150
10 2000147
11 2008132
12 2011131
13 1998128
14 2008123
15 2002122
16 1992120
17 2000107
18 2010106
19 2004103
20 201094

About Stefan Kubicka

Stefan Kubicka is a scholar working on Oncology, Surgery, Molecular Biology, Hepatology and Pulmonary and Respiratory Medicine, having authored 162 papers that have together received 6.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (39 papers), Virus-based gene therapy research (23 papers), Gastric Cancer Management and Outcomes (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cancer Treatment and Pharmacology (16 papers), RNA Interference and Gene Delivery (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers) and Hepatitis B Virus Studies (11 papers). The work is most often cited by research in Hepatology (1.6k citations), Oncology (2.1k citations), Cancer Research (637 citations), Epidemiology (1.1k citations) and Molecular Biology (2.2k citations). Stefan Kubicka has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Michael P. Manns, Christian Trautwein, Lars Zender, Florian Kühnel, Dirk Arnold, Thomas Wirth, Nisar P. Malek, Hans L. Tillmann, K. Lenhard Rudolph and Bettina Mundt. Their work appears in journals such as Journal of Clinical Oncology, Journal of Hepatology, Hepatology, Annals of Oncology and Ultraschall in der Medizin - European Journal of Ultrasound.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact